Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 23,100 shares at $2.23 ($52K) on 2024-08-21, disclosed to the SEC on 2024-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.23 | 15,000 | $33K | 64.7% |
| 2 | $2.25 | 8,100 | $18K | 35.3% |
| Total | $2.24 avg | 23,100 | $52K | 100% |
| Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |
| IMMX | BUY | 2023-09-12 | $25K | — | Filing → |